Skip to Content

APO MEL 7.5 (Meloxicam 7.5 mg)

Pill imprint APO MEL 7.5 has been identified as Meloxicam 7.5 mg.

Meloxicam is used in the treatment of inflammatory conditions; osteoarthritis; fibromyalgia; rheumatoid arthritis; tendonitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Meloxicam 7.5 mg APO MEL 7.5 Front
Meloxicam 7.5 mg APO MEL 7.5 Back
Meloxicam 7.5 mg APO MEL 7.5
Meloxicam 7.5 mg APO MEL 7.5
MEL 7.5
7.5 mg
6.00 mm
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
N - Not a controlled drug
Apotex Corp.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68071-0528 Nucare Pharmaceuticals Inc (repackager)
33261-0070 Aidarex Pharmacuticals, LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.